Porton Fine Chemicals Ltd. | Ownership
Companies that own Porton Fine Chemicals Ltd.
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
7,324,595
2.38%
2,565,404
0.26%
12/31/2017
China Investment Corp. (Investment Management)
6,413,250
2.08%
0
0.02%
09/30/2017
Bosera Asset Management Co., Ltd.
5,870,446
1.9%
-1,749,250
0.06%
09/30/2017
Baoying Fund Management Co., Ltd.
1,761,189
0.56%
1,637,889
0.09%
12/31/2017
China Asset Management Co., Ltd.
1,304,471
0.42%
1,304,471
0.01%
12/31/2017
The Vanguard Group, Inc.
321,250
0.1%
0
0%
07/31/2018
GF Fund Management Co., Ltd.
126,827
0.04%
10,300
0%
12/31/2017
China Southern Asset Management Co., Ltd.
4,800
0%
-38,400
0%
12/31/2017
Hwabao WP Fund Management Co., Ltd.
3,400
0%
-600
0%
12/31/2017
Chang Xin Asset Management Co., Ltd.
0
0%
-35,400
0%
12/31/2017
Address |
Fangzheng Avenue Chongqing Chongqing 400714 China
|
Employees
|
- |
Website |
http://www.porton.cn |
Updated |
07/08/2019 |
Porton Pharma Solutions Ltd. engages in the research and development and manufacture of pharmaceutical products and active pharmaceutical ingredients. It offers anti-viral, anti-diabetic, anti-hypertensive, anti-cancer, analgesic, hypolipidemic, and antibacterial drug treatment. The company was founded on July 7, 2005 and is headquartered in Chongqing, China. |